• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    58 Biggest Movers From Yesterday

    5/24/22 5:29:12 AM ET
    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ADGI alert in real time by email

    Gainers

    • Catalyst Biosciences, Inc. (NASDAQ:CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) surged 66.9% to settle at $2.32 after Maxim Group reiterated a Buy rating on the stock and announced a $6 price target.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) rose 58% to settle at $3.16.
    • View, Inc. (NASDAQ:VIEW) gained 43.4% to close at $0.9765.
    • Predictive Oncology Inc. (NASDAQ:POAI) gained 40.7% to close at $0.38. Predictive Oncology recently reported closing of $7.2 million registered direct offerings.
    • Standard BioTools Inc. (NASDAQ:LAB) surged 33.3% to close at $2.60.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) shares jumped 32.8% to close at $0.6889 on Monday after jumping around 14% on Friday.
    • Neonode Inc. (NASDAQ:NEON) jumped 28.8% to settle at $5.59. Neonode recently posted a Q1 loss of $0.10 per share.
    • O2Micro International Limited (NASDAQ:OIIM) shares climbed 28.6% to close at $3.78. O2Micro announced the receipt of an updated preliminary non-binding proposal to acquire the company.
    • Sonder Holdings Inc. (NASDAQ:SOND) gained 27.4% to settle at $2.23.
    • Mesa Royalty Trust (NYSE:MTR) jumped 25.8% to close at $18.38.
    • GoldMining Inc. (NYSE:GLDG) surged 25% to settle at $1.35.
    • VMware, Inc. (NYSE:VMW) rose 24.8% to close at $119.43 following several reports Broadcom is in talks to acquire the company.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) gained 24.4% to close at $2.86.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) surged 22.9% to close at $1.61.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) jumped 22.5% to close at $0.95.
    • United-Guardian, Inc. (NASDAQ:UG) jumped 22% to close at $20.00. United-Guardian recently posted Q1 EPS of $0.20.
    • Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) jumped 21.1% to settle at $2.18 after Innoviva announced it will acquire the company for $2.20 per share.
    • BIOLASE, Inc. (NASDAQ:BIOL) jumped 19.9% to settle at $5.12.
    • Forge Global Holdings, Inc. (NYSE:FRGE) shares gained 18.9% to close at $21.05 after dipping 15% on Friday.
    • Troika Media Group, Inc. (NASDAQ:TRKA) rose 18.4% to close at $0.7908.
    • Bright Green Corporation (NASDAQ:BGXX) gained 18% to close at $13.28 after dropping around 28% on Friday.
    • Nerdy, Inc. (NYSE:NRDY) surged 18% to close at $2.10.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) jumped 16.1% to close at $2.38 after climbing 25% on Friday.
    • Rallybio Corporation (NASDAQ:RLYB) gained 15% to close at $12.66.
    • BTCS Inc. (NASDAQ:BTCS) jumped 14.4% to settle at $2.70.
    • Origin Agritech Limited (NASDAQ:SEED) climbed 14.3% to close at $7.44. Origin Agritech received order for 20,000 metric tons of nutritionally enhanced corn.
    • TreeHouse Foods, Inc. (NYSE:THS) gained 11.7% to settle at $40.98. Truist Securities upgraded Treehouse Foods from Hold to Buy and raised the price target from $35 to $50.
    • Repare Therapeutics Inc. (NASDAQ:RPTX) rose 10.3% to close at $9.32. Repare Therapeutics recently posted a Q1 loss of $0.83 per share.
    • SurgePays, Inc. (NASDAQ:SURG) climbed 9% to close at $4.83. Surgepays recently posted a Q1 loss of $0.10 per share.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 8.5% to close at $5.77 after jumping 40% on Friday.
    • American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) gained 6.8% to close at $7.21. American Axle is exploring a sale, Bloomberg reported.


    Losers

    • Nymox Pharmaceutical Corporation (NASDAQ:NYMX) tumbled 63.9% to close at $0.4555 on Monday after the company received a Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.
    • Inotiv, Inc. (NASDAQ:NOTV) dipped 28.3% to close at $13.14. Inotiv said on May 18, U.S. Department of Justice executed a search and seizure warrant on Cumberland, Virginia facility.
    • Liquidia Corporation (NASDAQ:LQDA) dropped 18.8% to settle at $4.70. Liquidia Technologies recently posted a Q1 loss of $0.30 per share.
    • EBET, Inc. (NASDAQ:EBET) fell 18.2% to settle at $3.15.
    • Athersys, Inc. (NASDAQ:ATHX) declined 17.9% to close at $0.2140. B of A Securities downgraded Athersys from Neutral to Underperform and lowered the price target from $1 to $0.25.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) dipped 17.4% to close at $2.56. TherapeuticsMD shares gained around 37% on Friday after the company announced that it has received FDA approval of its supplemental New Drug Application for ANNOVERA.
    • Tiziana Life Sciences PLC (NASDAQ:TLSA) declined 17.4% to settle at $0.7107.
    • Harpoon Therapeutics, Inc. (NASDAQ:HARP) fell 16.1% to settle at $2.14.
    • ShiftPixy, Inc. (NASDAQ:PIXY) shares slipped 16.1% to close at $0.3526.
    • Performance Shipping Inc. (NASDAQ:PSHG) dropped 16% to close at $2.36.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 15.5% to close at $1.86.
    • NanoViricides, Inc. (NYSE:NNVC) dipped 15% to close at $2.21 after jumping around 40% on Friday.
    • Endo International plc (NASDAQ:ENDP) fell 14.9% to settle at $0.3957.
    • Farmmi, Inc. (NASDAQ:FAMI) dropped 14.6% to settle at $0.0665. Farmmi Monday received determination from Nasdaq to delist the company's securities from The Nasdaq Capital Market because the company's securities have had a closing bid price below $0.10 for ten consecutive trading days.
    • Avaya Holdings Corp. (NYSE:AVYA) declined 14.4% to close at $4.11.
    • Foghorn Therapeutics Inc. (NASDAQ:FHTX) fell 12.4% to close at $11.84. Morgan Stanley maintained Foghorn Therapeutics with an Overweight and lowered the price target from $26 to $25.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) shares fell 11.5% to close at $2.72 after effect of 1:12 reverse stock split.
    • Nordic American Tankers Limited (NYSE:NAT) dipped 11.2% to close at $2.37.
    • Carvana Co. (NYSE:CVNA) fell 9.9% to close at $30.24.
    • ATRenew Inc. (NYSE:RERE) fell 9.6% to close at $2.73.
    • Adagio Therapeutics, Inc. (NASDAQ:ADGI) fell 9.5% to close at $2.67.
    • Leju Holdings Limited (NYSE:LEJU) slipped 8.3% to settle at $4.45 after climbing over 53% on Friday.
    • CareDx, Inc (NASDAQ:CDNA) fell 7.5% to close at $23.92. CareDx said its CFO Ankur Dhingra notified the company of his intent to resign effective as of end of day on May 25, 2022.
    • PowerSchool Holdings, Inc. (NYSE:PWSC) fell 5.7% to close at $12.31. The company recently posted downbeat quarterly earnings.
    • The Gap, Inc. (NYSE:GPS) tumbled 5.5% to close at $10.33. Citigroup downgraded Gap from Neutral to Sell and lowered the price target from $13 to $8.
    • XPeng Inc. (NYSE:XPEV) fell 5.5% to close at $21.98 after the company reported Q1 financial results.
    Get the next $ADGI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADGI
    $AEMD
    $ALLR
    $ATHX

    CompanyDatePrice TargetRatingAnalyst
    Crescent Biopharma Inc.
    $CBIO
    1/28/2026$35.00Overweight
    Piper Sandler
    American Axle & Manufacturing Holdings Inc.
    $AXL
    1/27/2026$17.00Buy
    BWS Financial
    Crescent Biopharma Inc.
    $CBIO
    1/21/2026$35.00Buy
    Guggenheim
    CareDx Inc.
    $CDNA
    1/6/2026$26.00Buy → Hold
    Craig Hallum
    Foghorn Therapeutics Inc.
    $FHTX
    12/18/2025$11.00Buy
    BTIG Research
    NanoViricides Inc.
    $NNVC
    12/16/2025Buy
    Alliance Global Partners
    Carvana Co.
    $CVNA
    12/15/2025$500.00Buy
    Argus
    Forge Global Holdings Inc.
    $FRGE
    12/12/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    More analyst ratings

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Cohn Charles K. bought $240,635 worth of shares (197,242 units at $1.22) (SEC Form 4)

    4 - Nerdy Inc. (0001819404) (Issuer)

    12/18/25 9:04:27 AM ET
    $NRDY
    Other Consumer Services
    Real Estate

    Chief Executive Officer Cohn Charles K. bought $236,743 worth of shares (174,076 units at $1.36) (SEC Form 4)

    4 - Nerdy Inc. (0001819404) (Issuer)

    12/17/25 9:15:29 AM ET
    $NRDY
    Other Consumer Services
    Real Estate

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    SEC Filings

    View All

    BTCS Inc. filed SEC Form 8-K: Other Events

    8-K - BTCS Inc. (0001436229) (Filer)

    2/6/26 4:15:24 PM ET
    $BTCS
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Crescent Biopharma Inc.

    SCHEDULE 13G/A - CRESCENT BIOPHARMA, INC. (0001253689) (Subject)

    2/5/26 1:20:38 PM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by American Axle & Manufacturing Holdings Inc.

    SCHEDULE 13G - Dauch Corp (0001062231) (Subject)

    2/5/26 1:16:32 PM ET
    $AXL
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merchants Bancorp Set to Join S&P SmallCap 600

    NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Merchants Bancorp (NASD: MBIN) will replace TreeHouse Foods Inc. (NYSE:THS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 11. Investindustrial S.A. and its affiliates are acquiring Treehouse Foods in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Feb 11, 2026 S&P SmallCap 600 Addition Merchants Bancorp MBIN Financial Feb 11, 2026 S&P SmallCap 600 Deletion TreeHouse Foods THS Consumer Staples ABOUT S&P DOW

    2/6/26 6:24:00 PM ET
    $MBIN
    $SPGI
    $THS
    Major Banks
    Finance
    Finance: Consumer Services
    Packaged Foods

    Dauch to Announce Fourth Quarter Financial Results on February 13th

    DETROIT, Feb. 6, 2026 /PRNewswire/ -- Dauch Corporation, (NYSE:DCH, LSE: DCH)), formerly known as American Axle & Manufacturing, Inc, will hold a conference call to discuss fourth quarter financial results and other related matters at 10:00 a.m. ET on Friday, February 13, 2026. A press release announcing the results will be issued before the market opens on the same day and will be available at www.dauch.com. To participate by phone, please dial: (877) 883-0383 from the United States (412) 902-6506 from outside the United States Callers should reference access code 1164659. To

    2/6/26 8:00:00 AM ET
    $AXL
    $DCH
    Auto Parts:O.E.M.
    Consumer Discretionary

    Nerdy to Announce Fourth Quarter and Full Year 2025 Results on February 26, 2026

    Nerdy Inc. (NYSE:NRDY), a leading platform for delivering live online learning, today announced the Company will release its fourth quarter and full year financial results for the period ended December 31, 2025 after the U.S. stock market closes on Thursday, February 26, 2026. Following the release, Nerdy management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial and operating results. Interested parties in the U.S. may listen to the call by dialing 1-833-470-1428. International callers can dial 1-404-975-4839. The Access Code is 541162. A live webcast of the call will also be available on Nerdy's investor relations website at https://w

    2/5/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Crescent Biopharma with a new price target

    Piper Sandler initiated coverage of Crescent Biopharma with a rating of Overweight and set a new price target of $35.00

    1/28/26 7:10:21 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BWS Financial initiated coverage on American Axle with a new price target

    BWS Financial initiated coverage of American Axle with a rating of Buy and set a new price target of $17.00

    1/27/26 9:29:46 AM ET
    $AXL
    Auto Parts:O.E.M.
    Consumer Discretionary

    Guggenheim initiated coverage on Crescent Biopharma with a new price target

    Guggenheim initiated coverage of Crescent Biopharma with a rating of Buy and set a new price target of $35.00

    1/21/26 8:54:45 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Gottschalk Adrian

    4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)

    2/6/26 4:01:11 PM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & CFO May Christopher John was granted 287,879 shares, increasing direct ownership by 40% to 1,014,968 units (SEC Form 4)

    4 - Dauch Corp (0001062231) (Issuer)

    2/4/26 5:35:10 PM ET
    $AXL
    Auto Parts:O.E.M.
    Consumer Discretionary

    President Driveline Lynch Michael Joseph was granted 287,879 shares, increasing direct ownership by 54% to 818,889 units (SEC Form 4)

    4 - Dauch Corp (0001062231) (Issuer)

    2/4/26 5:35:05 PM ET
    $AXL
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Nerdy Inc.

    SC 13D/A - Nerdy Inc. (0001819404) (Subject)

    12/4/24 4:01:10 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    SEC Form SC 13D filed by Sonder Holdings Inc.

    SC 13D - Sonder Holdings Inc. (0001819395) (Subject)

    11/27/24 4:15:36 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Leadership Updates

    Live Leadership Updates

    View All

    Merchants Bancorp Set to Join S&P SmallCap 600

    NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Merchants Bancorp (NASD: MBIN) will replace TreeHouse Foods Inc. (NYSE:THS) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 11. Investindustrial S.A. and its affiliates are acquiring Treehouse Foods in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Feb 11, 2026 S&P SmallCap 600 Addition Merchants Bancorp MBIN Financial Feb 11, 2026 S&P SmallCap 600 Deletion TreeHouse Foods THS Consumer Staples ABOUT S&P DOW

    2/6/26 6:24:00 PM ET
    $MBIN
    $SPGI
    $THS
    Major Banks
    Finance
    Finance: Consumer Services
    Packaged Foods

    GoldMining Appoints Martin Dumont as VP, Corporate Development and Investor Relations

    VANCOUVER, BC, Jan. 22, 2026 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX:GOLD, NYSE:GLDG) is pleased to announce the appointment of Martin Dumont as Vice President, Corporate Development & Investor Relations. Alastair Still, President & Chief Executive Officer of GoldMining commented: "We are pleased to welcome Martin to the GoldMining team. His mining industry experience across corporate development, capital markets, and investor relations within the gold sector will play a key role as we continue to advance our portfolio and pursue value-accretive opp

    1/22/26 6:30:00 AM ET
    $GLDG
    $GROY
    $USGO
    Precious Metals
    Basic Materials

    Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

    Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced that its Shareholders (as defined below) have approved the acquisition of all of the issued and outstanding common shares of the Company (the "Common Shares" and the holders of the Common Shares, the "Shareholders") by XenoTherapeutics, Inc. and Xeno Acquisition Corp. (jointly "Xeno") a non-profit biotechnology company, by way of a statutory plan of arrangement (the "Transaction" or the "Arrangement") at the special meeting of Shareholders held today (the "Meeting"). The special resolution approving the Arrangement was approved by: (i) 99.76% of the votes cast b

    1/16/26 4:58:00 PM ET
    $RPTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Financials

    Live finance-specific insights

    View All

    Dauch to Announce Fourth Quarter Financial Results on February 13th

    DETROIT, Feb. 6, 2026 /PRNewswire/ -- Dauch Corporation, (NYSE:DCH, LSE: DCH)), formerly known as American Axle & Manufacturing, Inc, will hold a conference call to discuss fourth quarter financial results and other related matters at 10:00 a.m. ET on Friday, February 13, 2026. A press release announcing the results will be issued before the market opens on the same day and will be available at www.dauch.com. To participate by phone, please dial: (877) 883-0383 from the United States (412) 902-6506 from outside the United States Callers should reference access code 1164659. To

    2/6/26 8:00:00 AM ET
    $AXL
    $DCH
    Auto Parts:O.E.M.
    Consumer Discretionary

    Nerdy to Announce Fourth Quarter and Full Year 2025 Results on February 26, 2026

    Nerdy Inc. (NYSE:NRDY), a leading platform for delivering live online learning, today announced the Company will release its fourth quarter and full year financial results for the period ended December 31, 2025 after the U.S. stock market closes on Thursday, February 26, 2026. Following the release, Nerdy management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial and operating results. Interested parties in the U.S. may listen to the call by dialing 1-833-470-1428. International callers can dial 1-404-975-4839. The Access Code is 541162. A live webcast of the call will also be available on Nerdy's investor relations website at https://w

    2/5/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

    SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2025, at 4:15 p.m. ET on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session. Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10206585/1034

    2/4/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care